AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Inayat-Hussain, SH Winski, SL Ross, D
Citation: Sh. Inayat-hussain et al., Differential involvement of Caspases in hydroquinone-induced apoptosis in human leukemic HL-60 and Jurkat cells, TOX APPL PH, 175(2), 2001, pp. 95-103

Authors: Siegel, D Anwar, A Winski, SL Kepa, JK Zolman, KL Ross, D
Citation: D. Siegel et al., Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H : Quinone oxidoreductase 1, MOLEC PHARM, 59(2), 2001, pp. 263-268

Authors: Winski, SL Swann, E Hargreaves, RHJ Dehn, DL Butler, J Moody, CJ Ross, D
Citation: Sl. Winski et al., Relationship between NAD(P)H : quinone oxidoreductase 1 (NQO1) levels in aseries of stably transfected cell lines and susceptibility to antitumor quinones, BIOCH PHARM, 61(12), 2001, pp. 1509-1516

Authors: Beall, HD Winski, SL
Citation: Hd. Beall et Sl. Winski, Mechanisms of action of quinone-containing alkylating agents I: NQO1-directed drug development, FRONT BIOSC, 5, 2000, pp. D639-D648

Authors: Ross, D Kepa, JK Winski, SL Beall, HD Anwar, A Siegel, D
Citation: D. Ross et al., NAD(P)H : quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation,gene regulation and genetic polymorphisms, CHEM-BIO IN, 129(1-2), 2000, pp. 77-97

Authors: Stabler, SP Morton, RL Winski, SL Allen, RH White, CW
Citation: Sp. Stabler et al., Effects of parenteral cysteine and glutathione feeding in a baboon model of severe prematurity, AM J CLIN N, 72(6), 2000, pp. 1548-1557

Authors: Siegel, D McGuinness, SM Winski, SL Ross, D
Citation: D. Siegel et al., Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H :quinone oxidoreductase 2 (vol 9, pg 113, 1999), PHARMACOGEN, 9(3), 1999, pp. 419-419

Authors: Siegel, D McGuinness, SM Winski, SL Ross, D
Citation: D. Siegel et al., Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H :quinone oxidoreductase 1, PHARMACOGEN, 9(1), 1999, pp. 113-121

Authors: Winski, SL Hargreaves, RHJ Butler, J Ross, D
Citation: Sl. Winski et al., A new screening system for NAD(P)H : quinone oxidoreductase (NQO1)-directed antitumor quinones: Identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent, CLIN CANC R, 4(12), 1998, pp. 3083-3088
Risultati: 1-9 |